Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 8, 2004, Pages 779-783

  Arents, Nicolaas L A ^a   Thijs, Jacob C ^b   Van Zwet, Anton A ^a   Kleibeuker, Jan H ^c  

^a Public Health Service of Groningen   (Netherlands)

^b Bethesda Hospital   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Duodenal ulcer; Endoscopic diagnoses; Gastric ulcer; Helicobacter pylori; Idiopathic peptic ulcer disease; Non steroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DUODENUM ULCER; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER HEILMANNII; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHI-SQUARE DISTRIBUTION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PREVALENCE; STOMACH ULCER;

EID: 4043092233     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000108367.19243.73     Document Type: Review

References (23)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-S127.
2. Kuipers EJ, Thijs JC, Festen HPM. Helicobacter pylori and peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (suppl 2):59-69.
3. Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000; 12:635-640.
4. Borody TJ, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992; 87: 1403-1406.
5. Lanas A, Remacha B, Sainz R, Hirschowitz BI. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Am J Gastroenterol 2000; 95:513-519.
6. Nensey YM, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991; 91:15-18.
7. Howden CW. What causes Helicobacter pylori negative non-NSAID-related ulcers? In: Hunt RH, Tytgat GNJ (editors). Helicobacter pylori. Basic Mechanisms to Clinical Cure 2000. Dordrecht: Kluwer Academic Publishers; 2000, pp. 339-345.
8. Hirschowitz BI, Lanas A. Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. Gastroenterology 1998; 114:883-892.
9. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JBD. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94: 1834-1840.
10. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD: the RBC H. pylori Study Group. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating Helicobacter pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996; 10:251-261.
11. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998; 93:574-578.
12. Lanza F, Ciociola AA, Sykes D, Heath A, McSorley DJ, Webb PM. Ranitidine bismuth citrate plus clarithromycin is effective in eradicating H. pylori, and preventing ulcer relapse. Gastroenterology 1996; 91:917.
13. Sprung DJ. The natural history of duodenal ulcer disease and how it relates to Helicobacter pylori. Am J Gastroenterol 1997; 92:1655.
14. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93:1409-1415.
15. Higuchi K, Arakawa T, Fuijwara Y, Uchida T, Tominaga K, Watanabe T, et al. Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am J Gastroenterol 1999; 94:3083-3084.
16. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88:505-509.
17. Gisbert JP, Blanco M, Mateos JM, Fernandez-Salazar L, Fernandez-Bermejo M, Cantero J, et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999; 44:2295-2302.
18. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, El-Omar E, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulcer. Gut 1993; 34:762-768.
19. Pan ZJ, Berg DE, van der Hulst R, Su WW, Raudonikiene A, Xiao SD, et al. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis 1998; 178:220-226.
20. Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996; 91:2125-2129.
21. Boom R, Sol CJA, Heijtink R, Wertheim-van Dillen PME, van der Noordaa J. Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol 1991; 29:1804-1811.
22. Reinbach DH, Cruickshank G, McColl KE. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 34:1344-1347.
23. Del Valle J, Cohen H, Laine L, Scheiman JM. Acid peptic disorders. In: Yamada Y (editor). Textbook of Gastroenterology. Philadelphia: Lippincott, Williams & Wilkins; 1999, pp. 2023-2045.